Tesfaw Alemu Kerie, Batra Nikhil N, Phan Cong T
aVitreo-retina Services, Roha Specialized Eye Clinic, Addis Ababa, Ethiopia.
bDepartment of Surgery, Section of Ophthalmology, Dartmouth Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
Case Rep Ophthalmol. 2022 Oct 10;13(3):770-776. doi: 10.1159/000525442. eCollection 2022 Sep-Dec.
We describe the clinical features and treatment outcome of a patient with combined central retinal vein occlusion and cilioretinal artery occlusion. A 52-year-old female presented to our clinic with decreased vision in the right eye for 4 days. Visual acuity and intraocular pressure were count fingers at 2&1/2M and 14 mm Hg in the right and 20/20 and 16 mm Hg in the left eye, respectively. Funduscopic exam and optical coherence tomography (OCT) of the right eye confirmed the diagnosis of concurrent cilioretinal artery occlusion and central retinal vein occlusion with segmental macular pallor in the territory of the cilioretinal artery, corresponding marked inner retina thickening on OCT and signs of vein occlusion. The patient received an intravitreal injection of bevacizumab and at 1-month follow-up, vision improved to 20/30 with corresponding anatomical improvement. It is very important to recognize combined central retinal vein occlusion and cilioretinal artery occlusion as they could be treated with intravitreal injections of anti-vascular endothelial growth factors with favorable treatment outcomes.
我们描述了一例视网膜中央静脉阻塞合并睫状视网膜动脉阻塞患者的临床特征及治疗结果。一名52岁女性因右眼视力下降4天前来我院就诊。右眼视力为眼前数指/2.5米，眼压为14毫米汞柱；左眼视力为20/20，眼压为16毫米汞柱。右眼的眼底检查及光学相干断层扫描（OCT）确诊为同时存在睫状视网膜动脉阻塞和视网膜中央静脉阻塞，在睫状视网膜动脉供血区域有节段性黄斑苍白，OCT显示相应的视网膜内层明显增厚及静脉阻塞迹象。该患者接受了玻璃体腔内注射贝伐单抗治疗，在1个月的随访中，视力提高到20/30，同时解剖结构也有相应改善。认识到视网膜中央静脉阻塞合并睫状视网膜动脉阻塞非常重要，因为玻璃体腔内注射抗血管内皮生长因子对其进行治疗可取得良好的治疗效果。
